Sinovac Biotech (SVA) Lifted to “Strong-Buy” at BidaskClub


Sinovac Biotech (NASDAQ:SVA) was upgraded by BidaskClub from a “buy” rating to a “strong-buy” rating in a report issued on Friday, March 30th. Shares of NASDAQ:SVA traded down $0.16 during trading on Friday, reaching $8.00. 41,147 shares of the stock were exchanged, compared to its average …

Source: Sinovac Biotech (SVA) Lifted to “Strong-Buy” at BidaskClub

Get real time updates directly on you device, subscribe now.

Leave A Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Subscribe To Inside Alpha

Take the first step toward gaining exclusive access & insight into the world’s wealthiest, savviest most successful investors:

Subscribe to Inside Alpha now – it could change your life forever & it’s FREE!

You're in! Check your inbox shortly for more details.